Clinical Trial Update: Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine Therapy [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes phase 1/2 testing of Pyrotinib plus Dalpiciclib isethionate with standard endocrine therapy for locally advanced breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib Isethionate (dalpiciclib)
• Pyrotinib (pyrotinib)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Locally Advanced Breast Cancer (LABC) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING